Trials / Conditions / ROS1 Gene Mutation

ROS1 Gene Mutation

7 registered clinical trials studyying ROS1 Gene Mutation — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies NCT05370469	University of Virginia	N/A
Unknown	Endobronchial Ultrasound Needle Aspiration With and Without Suction NCT05110950	Università Politecnica delle Marche	N/A
Recruiting	Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation NCT04322890	Hunan Province Tumor Hospital	Phase 2
Active Not Recruiting	Genetic Testing in Guiding Treatment for Patients With Brain Metastases NCT03994796	Alliance for Clinical Trials in Oncology	Phase 2
Completed	A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squam NCT04042558	Centre Francois Baclesse	Phase 2
Withdrawn	Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Ca NCT03868423	Sameek Roychowdhury	Phase 2
Completed	Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 NCT03049618	University of Southern California	Phase 2